Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenna R M Harvey

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2020
Multielectrode ArraysRussell Burley, Jenna R M Harvey
Physiological Reviews|March 13, 2020
Ion Channels Controlling Circadian Rhythms in Suprachiasmatic Nucleus ExcitabilityJenna R M Harvey, Amber E Plante, Andrea L Meredith
Scientific Reports|September 8, 2022
Tau isoform-specific enhancement of L-type calcium current and augmentation of afterhyperpolarization in rat hippocampal neuronsGeorgiana F Stan, Timothy W Church, Ellie Randall, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.
Journal of Medicinal Chemistry|August 31, 2023
Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
Frontiers in Neuroscience|September 17, 2025
NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2020
Multielectrode ArraysRussell Burley, Jenna R M Harvey
Physiological Reviews|March 13, 2020
Ion Channels Controlling Circadian Rhythms in Suprachiasmatic Nucleus ExcitabilityJenna R M Harvey, Amber E Plante, Andrea L Meredith
Scientific Reports|September 8, 2022
Tau isoform-specific enhancement of L-type calcium current and augmentation of afterhyperpolarization in rat hippocampal neuronsGeorgiana F Stan, Timothy W Church, Ellie Randall, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.
Journal of Medicinal Chemistry|August 31, 2023
Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
Frontiers in Neuroscience|September 17, 2025
NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 1